Pro Medicus Stock

Pro Medicus EBIT

The EBIT of Pro Medicus (PME.AX) as of Jul 22, 2026 is 165.25 M AUD. In the previous year, EBIT was 117.62 M AUD — a change of 40.49% (higher).

EBIT

165.25 MAUD

YoY

40.49%

Last updated:

In 2026, Pro Medicus's EBIT was 165.25 M AUD, a 40.49% increase from the 117.62 M AUD EBIT recorded in the previous year.

The Pro Medicus EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M AUD)
Date
EBIT (M AUD)
Jan 1, 2024
117.62 base
Jan 1, 2025
165.25 base
Jan 1, 2026 (e)
216.90 base
Jan 1, 2027 (e)
271.39 base
Jan 1, 2028 (e)
338.34 base
Jan 1, 2029 (e)
367.15 base
Jan 1, 2030 (e)
358.80 base
Jan 1, 2031 (e)
0.00 base
YEAREBIT (M AUD)
2031 est -
2030 est 358.80
2029 est 367.15
2028 est 338.34
2027 est 271.39
2026 est 216.90
2025 165.25
2024 117.62
2023 86.51
2022 61.96
2021 42.63
2020 30.24
2019 25.71
2018 14.84
2017 14.19
2016 9.59
2015 3.46
2014 2.54
2013 -0.99
2012 0.21
2011 1.40
2010 5.30
2009 6.50
2008 11.33
2007 9.73
2006 8.49
Access this data via the Eulerpool API

Pro Medicus Revenue

Pro Medicus Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
166.33 M AUD
117.62 M AUD
82.79 M AUD
Jan 1, 2025
220.54 M AUD
165.25 M AUD
115.22 M AUD
Jan 1, 2026 (e)
277.00 M AUD
216.90 M AUD
176.00 M AUD
Jan 1, 2027 (e)
356.66 M AUD
271.39 M AUD
199.85 M AUD
Jan 1, 2028 (e)
439.09 M AUD
338.34 M AUD
251.19 M AUD
Jan 1, 2029 (e)
475.96 M AUD
367.15 M AUD
278.52 M AUD
Jan 1, 2030 (e)
490.19 M AUD
358.80 M AUD
244.76 M AUD
Jan 1, 2031 (e)
533.94 M AUD
0.00 AUD
263.74 M AUD

Pro Medicus Margins

Pro Medicus stock margins

The Pro Medicus margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pro Medicus. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pro Medicus.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
99.82 %
70.71 %
49.78 %
Jan 1, 2025
99.86 %
74.93 %
52.24 %
Jan 1, 2026 (e)
99.86 %
78.30 %
63.54 %
Jan 1, 2027 (e)
99.86 %
76.09 %
56.03 %
Jan 1, 2028 (e)
99.86 %
77.05 %
57.21 %
Jan 1, 2029 (e)
99.86 %
77.14 %
58.52 %
Jan 1, 2030 (e)
99.86 %
73.20 %
49.93 %
Jan 1, 2031 (e)
99.86 %
0.00 %
49.40 %

Pro Medicus Stock analysis

What does Pro Medicus do? Pro Medicus Ltd. is an Australian company specializing in the development and distribution of medical imaging software solutions. The company was founded in 1983 and is headquartered in Melbourne. Pro Medicus is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Pro Medicus's EBIT

Pro Medicus's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Pro Medicus's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Pro Medicus's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Pro Medicus’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Pro Medicus stock

EBIT of Pro Medicus is 165.25 M AUD in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Pro Medicus

All Key Metrics — Pro Medicus